MSK earns merit extension from NCI

Undergrad intern at MSK poses a profound question: What if Henrietta Lacks had a Black doctor?

Every summer since 2010, ten undergraduate students from diverse backgrounds get the opportunity to explore any curiosities they might have about careers in medicine at Memorial Sloan Kettering Cancer Center.

October 04, 2024

Vol.50 No.37

By Claire Marie Porter

In Brief

Dana-Farber, Fred Hutch, MSK, Hopkins form Cancer AI Alliance

Four NCI-designated cancer centers—Dana-Farber Cancer Institute, Fred Hutch Cancer Center, Memorial Sloan Kettering Cancer Center, and The Sidney Kimmel Comprehensive Cancer Center and Whiting School of Engineering at Johns Hopkins—have joined together and secured funding from AWS, Deloitte, Microsoft, and NVIDIA, to create the Cancer AI Alliance.

October 04, 2024

Vol.50 No.37

Clinical

Factors outside CAR T-cell therapy are associated with increased risk of secondary cancers after the treatment, meta-analysis shows
Subgroup analysis suggests risk of secondary cancers after CAR T-cell therapy is similar to risk after other therapies

A meta-analysis of 25 studies—totaling over 5,000 participants—focused on a question that has been troubling patients, physicians, and regulators: Does treatment with CAR T-cell therapy contribute to the development of secondary cancers?

September 13, 2024

Vol.50 No.34

By McKenzie Prillaman

Conversation with The Cancer Letter

Lei Zheng got his PhD in San Antonio; now he returns as cancer center director at Mays

In 1996, Lei Zheng, a graduate of Peking Union Medical College, enrolled in the doctorate program at what was then known as the Cancer Therapy & Research Center in San Antonio.

Roswell Park earns “exceptional” rating from NCI with best-ever core grant

Roswell Park Comprehensive Cancer Center has earned the highest—”exceptional”—rating from NCI as part of renewal of the grant the institution has held since 1972.

June 14, 2024

Vol.50 No.24

In Brief

NCI seeking director of Office of Cancer Centers

NCI is seeking an innovative leader to serve as the director, Office of Cancer Centers.

June 14, 2024

Vol.50 No.24

MSK earns merit extension from NCI

YOU MAY BE INTERESTED IN

Undergrad intern at MSK poses a profound question: What if Henrietta Lacks had a Black doctor?

Dana-Farber, Fred Hutch, MSK, Hopkins form Cancer AI Alliance

Factors outside CAR T-cell therapy are associated with increased risk of secondary cancers after the treatment, meta-analysis shows
Subgroup analysis suggests risk of secondary cancers after CAR T-cell therapy is similar to risk after other therapies

Lei Zheng got his PhD in San Antonio; now he returns as cancer center director at Mays

Roswell Park earns “exceptional” rating from NCI with best-ever core grant

NCI seeking director of Office of Cancer Centers

Renew today!

Subscriber content

Never miss an issue!

Login

MSK earns merit extension from NCI

YOU MAY BE INTERESTED IN

Undergrad intern at MSK poses a profound question: What if Henrietta Lacks had a Black doctor?

Dana-Farber, Fred Hutch, MSK, Hopkins form Cancer AI Alliance

Factors outside CAR T-cell therapy are associated with increased risk of secondary cancers after the treatment, meta-analysis showsSubgroup analysis suggests risk of secondary cancers after CAR T-cell therapy is similar to risk after other therapies

Lei Zheng got his PhD in San Antonio; now he returns as cancer center director at Mays

Roswell Park earns “exceptional” rating from NCI with best-ever core grant

NCI seeking director of Office of Cancer Centers

Never miss an issue!

Login

Factors outside CAR T-cell therapy are associated with increased risk of secondary cancers after the treatment, meta-analysis shows
Subgroup analysis suggests risk of secondary cancers after CAR T-cell therapy is similar to risk after other therapies